Search

Search Results
Results 641 - 650 of 6900 for A-fil
  • Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface
    News - 5 Feb 2007
    To accurately transport pharmaceutical agents to their specific target organs or cell types, you need a good carrier: nanoscopic capsules with surface elements that can "recognize" the target in...
  • Major stem cell discovery
    News - 20 Jul 2005
    Research published in Nature tomorrow (21 July) will outline for the first time the stem cell origin of the structure of the neck and shoulders in vertebrates.
  • Within six months, one in three patients fail to take cardiovascular risk-lowering medications as prescribed
    News - 23 May 2005
    Therapy that includes medications to reduce high blood pressure and to lower lipid levels can reduce risk for heart disease, but within six months, more than a third of patients fail to take one or...
  • MicroVention awarded key patent for Smart Hydrogel
    News - 11 May 2005
    MicroVention announced today that the U.S. Patent and Trademark Office has awarded the company U.S. Patent No. 6,878,384 for its proprietary environmentally-responsive or "smart" hydrogel called...
  • Toronto hospitals implement new ethics strategy
    News - 2 May 2005
    Health care ethics gained the limelight during the recent battle over Terry Schiavo's fate, but ethical decision-making is already a growing part of the corporate culture at a number of Toronto...
  • Pfizer recalls epilepsy medicine
    News - 23 Apr 2005
    Pfizer has voluntarily recalled one lot (40,000 bottles) of 100 mg capsules of its epilepsy medication, Neurontin, after a manufacturing mechanical failure resulted in some bottles containing empty or...
  • Canadian prescription drugs
    News - 16 Nov 2004
    Canadian pharmacies that mail prescription drugs to U.S. patients have been backed into a no-win situation by the Canadian government and the provincial medical and pharmacy associations.
  • Ovidrel Pen
    Drug - 8 Oct 2025
    Consumer Medicine Information (CMI) about Ovidrel Pen intended for persons living in Australia.
  • Copaxone Pen
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Copaxone Pen intended for persons living in Australia.
  • Aimovig
    Drug - 23 Aug 2023
    Consumer Medicine Information (CMI) about Aimovig intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback